Healthcare giant Boots has entered the ‘cannabis medicines’ market.
Operating through Boots Online Doctor, SureLeaf will prescribe the drug to eligible clients suffering from a wide range of conditions, such as headaches, phantom limb pain, anxiety and insomnia.
Applicants must demonstrate that conventional treatments have proved unsuccessful. Academics at the University of Nottingham will monitor patient outcomes.
No benefit
For previous users, the retailer offers a £99 annual plan, which includes an initial assessment and four follow-up appointments — all without any in-person consultation. The lowest prescribed monthly dose of medicinal cannabis is expected to cost £35.
Boots’ Chief Healthcare Officer Jamie Kerruish claimed the scheme is about helping people living with ongoing pain to “explore appropriate options that could help them better manage their symptoms and improve their quality of life”.
Yet current guidelines from NHS Scotland state that medicinal cannabis-based products “are not recommended for routine use in the management of chronic pain. This takes into consideration the very limited evidence of clinically significant improvements in pain”.
While a study recently published in The Lancet Psychiatry reported “no benefit of cannabinoids” for some conditions, including anxiety, PTSD, and anorexia nervosa.
Deaths
In October, a coroner’s report on Jersey identified the consumption of medical cannabis as a significant contributory factor in the death of 66-year-old islander David Morgan in a house fire.
Deputy Viscount Matt Berry found that Morgan died from “acute carbon monoxide poisoning resulting from exposure to fire, contributed to by starvation/stress-induced ketoacidosis and the consumption of unlicensed CBPMs [cannabis-based products for medicinal use]”.
Earlier in the year, a Manchester coroner found that a private prescription for the drug by Curaleaf Clinic — which manufactures and distributes medicinal cannabis — played a part in the death by suicide of 34-year-old Oliver Robinson.
Commenting on the outcome, King’s College Hospital psychiatrist Professor Sir Robin Murray said: “These clinics are nothing more than drug dealers for the middle classes. What is happening is not what the legislation hoped to achieve – it has become a money-making business.”
Jersey to rein in liberal laws on medicinal cannabis
Cannabis academy’s teachings ‘biased’ and ‘dangerous’
